Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether F-18 FPCIT is effective and safe
radiopharmaceutical for the objective diagnosis of Parkinson's disease.